 | | DRUG: Betamethasone butyrate propionate | |
| Entry |
|
|---|
| Name |
Betamethasone butyrate propionate (JAN);
Antebate (TN) |
|---|
| Formula |
C29H39FO7
|
|---|
| Exact mass |
518.268
|
|---|
| Mol weight |
518.6142
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
| Therapeutic category: | 2646 |
| Product (DG00095): | D00244<JP> D00972<JP> D01357<JP/US> D01637<JP/US> D02032<JP> |
| Product (mixture): | D10788<JP> |
|
|---|
| Efficacy |
Anti-inflammatory, Glucocorticoid receptor agonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07225 | Glucocorticoid and mineralocorticoid receptor agonists/antagonists |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A07E INTESTINAL ANTIINFLAMMATORY AGENTS
A07EA Corticosteroids acting locally
A07EA04 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
C CARDIOVASCULAR SYSTEM
C05 VASOPROTECTIVES
C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05AA Corticosteroids
C05AA05 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
D DERMATOLOGICALS
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D07A CORTICOSTEROIDS, PLAIN
D07AC Corticosteroids, potent (group III)
D07AC01 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
D07X CORTICOSTEROIDS, OTHER COMBINATIONS
D07XC Corticosteroids, potent, other combinations
D07XC01 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H02 CORTICOSTEROIDS FOR SYSTEMIC USE
H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
H02AB Glucocorticoids
H02AB01 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
R RESPIRATORY SYSTEM
R01 NASAL PREPARATIONS
R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01AD Corticosteroids
R01AD06 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
R03BA Glucocorticoids
R03BA04 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01B ANTIINFLAMMATORY AGENTS
S01BA Corticosteroids, plain
S01BA06 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
S01CB Corticosteroids/antiinfectives/mydriatics in combination
S01CB04 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
S02 OTOLOGICALS
S02B CORTICOSTEROIDS
S02BA Corticosteroids
S02BA07 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
S03B CORTICOSTEROIDS
S03BA Corticosteroids
S03BA03 Betamethasone
D02032 Betamethasone butyrate propionate (JAN) <JP>
USP drug classification [BR:br08302]
Dermatological Agents
Dermatitis and Pruitus Agents
Glucocorticoids, Medium Potency
Betamethasone
D02032 Betamethasone butyrate propionate (JAN)
Glucocorticoids, High Potency
Betamethasone
D02032 Betamethasone butyrate propionate (JAN)
Glucocorticoids, Very High Potency
Betamethasone
D02032 Betamethasone butyrate propionate (JAN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
26 Epidermides
264 Analgesics, anti-itchings, astringents, anti-inflammatory agents
2646 Adrenocorticotropic hormones
D02032 Betamethasone butyrate propionate (JAN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
DG00095 Betamethasone
D02032 Betamethasone butyrate propionate
Drug classes [BR:br08332]
Anti-inflammatory
DG01955 Corticosteroid
D02032 Betamethasone butyrate propionate
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C1 (GR)
D02032 Betamethasone butyrate propionate (JAN) <JP>
Topical steroids potency [br08317.html]
Classification in Japan
D02032
Drug groups [BR:br08330]
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
DG00095 Betamethasone
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 37
1 C2x C 15.6561 -19.4690
2 C5x C 15.6561 -20.8194
3 C2x C 16.8256 -21.4948
4 C2y C 17.9952 -20.8194
5 C1z C 17.9952 -19.4690
6 C2x C 16.8256 -18.7937
7 C1x C 19.1647 -21.4948
8 C1x C 20.3344 -20.8194
9 C1y C 20.3344 -19.4690
10 C1z C 19.1647 -18.7937
11 C1y C 21.5039 -18.7937
12 C1z C 21.5039 -17.4432
13 C1x C 20.3344 -16.7679
14 C1y C 19.1647 -17.4432
15 C1x C 23.8430 -18.7937
16 C1y C 23.8430 -17.4432
17 C1z C 22.6735 -16.7679
18 C1a C 25.2197 -17.4517
19 C5a C 22.6737 -15.0019
20 C1a C 21.4866 -16.0984
21 O1a O 17.9476 -16.7404
22 C1a C 17.9831 -18.0546
23 O5x O 14.4453 -21.5185
24 X F 19.1493 -20.2006
25 O7a O 23.9078 -16.0487
26 O5a O 23.9029 -14.2923
27 C1b C 21.4828 -14.2991
28 O7a O 20.2708 -14.9989
29 C7a C 19.0588 -14.2991
30 C1b C 17.8467 -14.9989
31 O6a O 19.0588 -12.8996
32 C1a C 16.6320 -14.2975
33 C7a C 26.0073 -16.0487
34 O6a O 26.7103 -17.2661
35 C1b C 26.6970 -14.8538
36 C1b C 28.0922 -14.8536
37 C1a C 28.7947 -13.6363
BOND 40
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 1
6 1 6 2
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 9 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 10 14 1
17 11 15 1
18 15 16 1
19 16 17 1
20 12 17 1
21 16 18 1 #Up
22 17 19 1 #Up
23 12 20 1 #Up
24 14 21 1 #Up
25 5 22 1 #Up
26 2 23 2
27 10 24 1 #Down
28 17 25 1 #Down
29 19 26 2
30 19 27 1
31 27 28 1
32 28 29 1
33 29 30 1
34 29 31 2
35 30 32 1
36 25 33 1
37 33 34 2
38 33 35 1
39 35 36 1
40 36 37 1
|
|---|
|
» Japanese version » Back
|
|